Recall Radar

Disclaimer: Recall Radar is an informational summary of public FDA enforcement reports. It is not medical advice. Always confirm details with the FDA, the company, a pharmacist, or a doctor before making health decisions.

← All recalls · Drug recalls

Class IIDrug

fentaNYL Citrate recall

Summary

OurPharma LLC is recalling fentaNYL Citrate (drug). According to the FDA report, the reason is: Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product expiry (12/09/2026). The FDA rated this a Class II: the product may cause temporary or medically reversible health problems; serious harm is unlikely. Recall status: Ongoing.

Details from the FDA report

Product
fentaNYL Citrate, 1,000 mcg/100 mL (10mcg/mL) Injection solution in 100 mL, 0.9% NaCl Bag, OurPharma LLC, 2512 S. City Lake, Fayetteville, AR, NDC 73013-1013-01.
Reason
Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product expiry (12/09/2026).
Lot / code info
Lot #: 101301260605, BUD: 12/9/2026.
Quantity
1,610 bags
Distribution
Nationwide within the U.S
Recalling company
OurPharma LLC, Fayetteville, AR United States
Recall started
September 3, 2026
FDA report date
September 16, 2026
Classification
Class II: The product may cause temporary or medically reversible health problems; serious harm is unlikely.
Voluntary / mandated
Voluntary: Firm initiated
Status
Ongoing
Recall number
D-0864-2026

What to do

View the FDA source record (openFDA) · FDA recalls page

Helpful guides

All guides

Get recall alerts by email

One short digest when new FDA food, supplement or drug recalls are posted, with the most serious (Class I) first. Free; unsubscribe anytime.

Powered by Buttondown. You may need to confirm your address by email.